UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide

European journal of cancer care, 2010-03, Vol.19 (2), p.200-204

2010

Volltextzugriff (PDF)

Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide : A single center experience

Oncology reports, 2008-08, Vol.20 (2), p.385-390

2008

Volltextzugriff (PDF)

785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY

Journal of hepatology, 2009, Vol.50, p.S287-S287

2009

Volltextzugriff (PDF)

Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases

Cancer, 2008-11, Vol.113 (9), p.2524-2531

2008

Volltextzugriff (PDF)

Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients

Clinical cancer research, 1995-04, Vol.1 (4), p.377-384

1995

Volltextzugriff (PDF)

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

European journal of cancer supplements, 2008-10, Vol.6 (14), p.119-120

2008

Volltextzugriff (PDF)

Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study

European journal of cancer supplements, 2008, Vol.6 (7), p.173-173

2008

Volltextzugriff (PDF)

A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1085-1085

2009

Volltextzugriff (PDF)

Low protracted dose of temozolomide (TMZ) and concurrent radiotherapy for brain metastasis of solid tumors

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.12525-12525

2007

Volltextzugriff (PDF)

Tailored combined treatment with radiofrequency ablation plus octreotide in advanced hepatocellular carcinoma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15173-15173

2007

Volltextzugriff (PDF)

Intravesical gemcitabine versus mitomycin for recurrent superficial bladder tumors (Stages pTa and pT1): A randomized prospective study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5075-5075

2008

Volltextzugriff (PDF)

Temozolomide (TMZ) and radiation (XRT) for brain metastasis of solid tumors

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.1543-1543

2006

Volltextzugriff (PDF)

Phase II study of pegylated liposomal doxorubicin plus vinorelbine in metastatic breast cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10718-10718

2006

Volltextzugriff (PDF)

α-Interferon Induces Depletion of Intracellular Iron Content and Up Regulation of Functional Transferrin Receptors on Human Epidermoid Cancer kb Cells

Biochemical and biophysical research communications, 1994-08, Vol.203 (1), p.281-288

1994

Volltextzugriff (PDF)

Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits

Clinical cancer research, 1996-01, Vol.2 (1), p.207-214

1996

Volltextzugriff (PDF)

Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1577-1577

2004

Volltextzugriff (PDF)

Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1577-1577

2004

Volltextzugriff (PDF)

α‐interferon potentiates epidermal growth factor receptor‐mediated effects on human epidermoid carcinoma KB cells

International journal of cancer, 1995-05, Vol.61 (3), p.342-347

1995

Volltextzugriff (PDF)

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration : Antitumor activity and immunomodulatory effects

American journal of clinical oncology, 1998-02, Vol.21 (1), p.48-53

1998

Volltextzugriff (PDF)

Extracellular adenosine 5′ triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation

Immunology letters, 1997-02, Vol.55 (2), p.69-78

1997

Volltextzugriff (PDF)

Tumour cell resistance to non-MHC-restricted lymphocytes : molecular mechanisms and clinical implications

Cancer Immunology, Immunotherapy, 1998-05, Vol.46 (3), p.121-127

1998

Volltextzugriff (PDF)

Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells

Biochemical and biophysical research communications, 1994-08, Vol.203 (1), p.281-288

1994

Volltextzugriff (PDF)

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells

Anti-cancer drugs, 1995-04, Vol.6 (2), p.285-290

1995

Volltextzugriff (PDF)

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta super(1) integrin profile of cultured human tumor cells

Anti-cancer drugs, 1995-01, Vol.6 (2), p.285-290

1995

Volltextzugriff (PDF)

Simultaneous Determination of Caffeine and Chlorogenic Acids in Green Coffee by UV/Vis Spectroscopy

Journal of chemistry, 2017-01, Vol.2017, p.1-8

2017

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(12)
Biological And Medical Sciences
(8)
Oncology
(8)
Medical Sciences
(7)
Aged
(6)
Female
(6)
Middle Aged
(6)
Adult
(4)
Antineoplastic Agents
(4)
Male
(4)
Pharmacology. Drug Treatments
(4)
Physical Sciences
(4)
Animals
(3)
Biochemistry & Molecular Biology
(3)
Chemistry
(3)
Education & Educational Research
(3)
Immunotherapy
(3)
Killer Cells, Lymphokine-Activated - Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide

Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide : A single center experience

785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY

Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases

Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study

A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial

Low protracted dose of temozolomide (TMZ) and concurrent radiotherapy for brain metastasis of solid tumors

Tailored combined treatment with radiofrequency ablation plus octreotide in advanced hepatocellular carcinoma

Intravesical gemcitabine versus mitomycin for recurrent superficial bladder tumors (Stages pTa and pT1): A randomized prospective study

Temozolomide (TMZ) and radiation (XRT) for brain metastasis of solid tumors

Phase II study of pegylated liposomal doxorubicin plus vinorelbine in metastatic breast cancer

α-Interferon Induces Depletion of Intracellular Iron Content and Up Regulation of Functional Transferrin Receptors on Human Epidermoid Cancer kb Cells

Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits

Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study

Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study

α‐interferon potentiates epidermal growth factor receptor‐mediated effects on human epidermoid carcinoma KB cells

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration : Antitumor activity and immunomodulatory effects

Extracellular adenosine 5′ triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation

Tumour cell resistance to non-MHC-restricted lymphocytes : molecular mechanisms and clinical implications

Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta super(1) integrin profile of cultured human tumor cells

Simultaneous Determination of Caffeine and Chlorogenic Acids in Green Coffee by UV/Vis Spectroscopy

Suchergebnisse filtern